Cancer Links
@LinksCancer
Followers
247
Following
8K
Media
12
Statuses
5K
🧬Sharing #CancerResearch, news, and breakthroughs. Links & Retweets 📰✨ #CancerAwareness #CancerSupport 💪💜
Europe
Joined June 2023
RT @jgong15: Excited to chair the #GIcancer session at the @binaytara 2025 Updates in Hematology/Oncology Conference, @DoubleTree @fresnoho….
0
15
0
RT @DrYukselUrun: Final OS results from IPATential150: Adding ipatasertib to abiraterone did not improve survival in mCRPC in PTEN loss by….
0
21
0
RT @SuyogCancer: 🔬 ADCs in Platinum-Sensitive Ovarian Cancer (PSOC) – Promising but early days 🧵👇.💥 Four ADCs in play:.• 🔗 Sac-TMT: Belotec….
0
32
0
RT @Dr_ElvinaA: Could ADCs go beyond FRα and HER2 in #OvarianCancer?.In 80 HGSOC samples:.✅FR@: 72%.✅HER2:%83.✅ CDH6: 72%.✅ TROP2: 78%.✅ B7….
0
24
0
RT @jgong15: @YJanjigianMD plenary session PhIII MATTERHORN periop FLOT +/- durva (up to 1 yr) in stage II-IVa G/GEJ adenoCA (90% PD-L1>1)….
0
17
0
RT @jgong15: @FASinicropeMD plenary session PhIII #ATOMIC adj 6 mos FOLFOX +/- atezo add’l 6 mos in #MSI-H stage III #coloncancer ➡️ median….
0
11
0
RT @jgong15: Dr. Elez @vallhebron @VHIO updated.results of BREAKWATER #1L #BRAFV600E MT #mCRC ➡️ PFS 12.8 mos/OS 30.3 mos FOLFOX-EC vs PFS….
0
12
0
RT @jgong15: Huge congrats to @CSCancerCenter 2nd yr heme/onc fellow Dr. Louisa Liu for her 2025 @ConquerCancerFd #YIA 🙌❗️❗️Way to represen….
0
9
0
RT @DrewMoghanaki: Just when you thought the horizon for locally advanced NSCLC couldn’t get brighter… along comes HORIZON-01: ChemoRadioth….
0
21
0
RT @dr_yakupergun: Unveiling the paradigm shift: systemic treatment strategies in small, node-negative breast cancer. Should we recommend a….
0
22
0
RT @DrJNaidoo: Final Analysis Ph I CHRYSALIS: Amivantamab in stage IV METexon14+ @JTOonline:. - 97pts (1L=16; 2L=28, prior MET TKI=53).- OR….
jto.org
Amivantamab is an EGFR-MET bispecific antibody with immune cell–directing activity. We assessed the safety and efficacy of amivantamab in participants with advanced NSCLC harboring primary MET exon...
0
14
0
RT @LeiDeng3: ❓What H/O programs sponsor What visas❓ .This year, Dr. Xia (Yaya) Wu @TuftsUniversity spearheaded a Visa project to survey th….
0
4
0
RT @matteolambe: Last post from #ESMOBreast25…I’m deeply grateful & really honored for the opportunity to chair together with Dr. Shani Pal….
0
5
0
RT @NiuSanford: Wow, this trial showed no OS benefit to FOLFIRINOX vs. single agent gemcitabine in locally advanced pancreas cancer (differ….
0
53
0
RT @matteolambe: Live from #ESMOBreastBCY…just got a couple of very precious gifts from my mentor & hero @AnnPartridgeMD ❤️.GRAZIE MILLE fo….
0
15
0
RT @DonjetaZeqa: Back home after an amazing #ESMOBreast25. Grateful to speak in two panels on BRCA mutations & IBC. Honored to share the st….
0
4
0